Medicine and Dentistry
Cohort Analysis
100%
Atrial Fibrillation
74%
Apoplexy
37%
Valvular Heart Disease
32%
Thromboembolism
32%
Bleeding
24%
Antithrombotic
23%
Anticoagulation
22%
Venous Thromboembolism
18%
Abdominal Aortic Aneurysm
16%
Mitral Valve Stenosis
16%
Major Bleeding
13%
Anticoagulant Therapy
13%
Diseases
11%
Vitamin K Antagonist
11%
Antithrombotic Therapy
10%
Hazard Ratio
10%
Antiplatelet
9%
Cardiovascular System
9%
Myocardial Infarction
9%
Malignant Neoplasm
9%
Warfarin
8%
Outpatient
8%
Childbirth
8%
New-Onset Atrial Fibrillation
8%
Transient Ischemic Attack
8%
Lung Cancer
8%
Salmonellosis
8%
Serotype
8%
Aortic Stenosis
8%
Biological Marker
8%
Schistosomiasis
8%
Schistosoma
8%
Bacterial Vaginosis
8%
Gestational Age
7%
Aortic Insufficiency
6%
Mitral Insufficiency
6%
Attributable Risk
6%
Retinol
6%
CHA2DS2-VASc Score
5%
Salmonella
5%
Keyphrases
Atrial Fibrillation
57%
National Cohort Study
57%
Valvular Heart Disease
24%
Thromboembolism
17%
Aortic Stenosis
16%
Warfarin
16%
Bleeding
14%
Major Bleeding
12%
Non-vitamin K Antagonist Oral Anticoagulants
12%
Anticoagulated Patients
10%
Stroke Assessment
9%
Oral Anticoagulation
8%
Bleeding Complications
8%
Comparative Effectiveness
8%
Small-area Analysis
8%
Intracerebral Hemorrhage
8%
Denmark
8%
Drug Therapy
8%
Cerebrovascular Accident
8%
Time Trends
8%
Bleeding Outcomes
8%
Evidence-based
8%
Aneurysmal Disease
8%
Cardioprotective Therapy
8%
Survivors
8%
Bleeding Risk Score
8%
Comparative Safety
8%
Edoxaban
8%
Heart Failure
8%
Oral Anticoagulant Therapy
8%
Use of Evidence
8%
Degenerative Mitral Stenosis
8%
Trends in Use
8%
Patients with Schizophrenia
8%
Mitral
8%
Female Genital Schistosomiasis
8%
Sexually Transmitted Infections
8%
Schistosoma
8%
Bacterial Vaginosis
8%
Phase 2 Randomized Controlled Trial
8%
Cardiovascular Outcomes
8%
Antithrombotic Therapy
8%
Cancer Patients
8%
In Cancer
8%
All-cause Mortality
8%
Vitamin K Antagonists
8%
Schizophrenia
7%
Mitral Stenosis
7%
Aortic Regurgitation
6%
Mitral Regurgitation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
75%
Atrial Fibrillation
65%
Anticoagulant Agent
31%
Venous Thromboembolism
26%
Warfarin
24%
Bleeding
24%
Abdominal Aortic Aneurysm
20%
Thromboembolism
19%
Disease
18%
Comorbidity
14%
All Cause Mortality
14%
Antiplatelet
13%
Antithrombotic Therapy
10%
Antivitamin K
10%
Brain Hemorrhage
9%
Heart Infarction
9%
Malignant Neoplasm
9%
Heart Failure
8%
Lung Cancer
8%
Valvular Heart Disease
8%
Aortic Stenosis
8%
Anticoagulation Therapy
8%
New-Onset Atrial Fibrillation
8%
Edoxaban
8%
Schistosomiasis
8%
Biological Marker
8%
Schistosoma
8%
Prevalence
6%
Cause of Death
5%
Coronary Artery Atherosclerosis
5%